AbbVie is trading 3.07% up at $258.02, with the move appearing primarily tied to healthcare-led sector rotation, not a new AbbVie-specific announcement.
- Healthcare stocks rally as technology shares weaken across the broader market.
- Wells Fargo raised its target to $300 from $295 and reiterated Overweight, citing hidradenitis suppurativa treatments as a growth driver.
- Elevated open-market activity accompanies healthcare outperformance as investors favor defensive assets amid rising yields, geopolitical uncertainty, and technology selling.